Delong up 7.4% as shareholder Evraz says steelmaker 'undervalued'

Delong up 7.4% as shareholder Evraz says steelmaker 'undervalued'

By: 
PC Lee
23/01/18, 12:05 pm

SINGAPORE (Jan 23): Delong Holdings, the Singapore-traded steelmaker with assets in China, jumped 26 cents to $3.76 with 182,000 shares traded.

The stock has risen 44% since Evraz Plc, a Russia steelmaker that owns a 15% stake in Delong, said in a Dec 2017 interview with Bloomberg that the company was undervalued because large investors have long ignored the stock.

Fair value could be US$4 billion to US$5 billion, compared with its current market value of about $200 million, said Aleksey Eberents, director for corporate strategy for Evraz in an emailed interview.

Delong’s enterprise value to EBITDA was less than 1, compared with a typical ratio in China of 10 to 12. Ebitda would be US$390 million in 2017, highest in seven years, he added.

Delong has US$620 million in cash and planning new projects, which could increase its value.

If the value of Evraz’s stake in Delong increased, then the company may sell it to fund other projects or pay higher dividends, Oleg Petropavlovskiy, analyst at BCS Global Markets, was quoted by Bloomberg as saying.

Margins weak for Riverstone but expansion plans on track

SINGAPORE (May 22): With margins under pressure at Riverstone Holdings, analysts say growth recovery would only be seen after 1Q19 given its expansion plans are on track. In 1Q19, Riverstone reported revenue grew 14.6% on the back of a higher annual glove capacity of 9 billion from a year ago. However, net profit declined 2.8% y-o-y to RM30.2 million, which CGS-CIMB deemed slightly disappointing at 21.3%/20.7% of its/consensus’ FY19F forecasts. CGS-CIMB analyst Colin Tan says the decline was mainly due to a drop in ASPs for healthcare gloves and higher taxation as a result of higher....
Read More >>

Health Management International kept at 'buy' on healthy business, demographic shift and rising affluence

SINGAPORE (May 22): Phillip Capital, Maybank KimEng and UOB KayHian all have “buy” calls on Health Management International after 3Q19 revenue rose on the back of resilient patient load growth and increasing average patient bill size. In the third quarter, patient load grew 1.3% y-o-y to 116,200 patients, driven by both inpatient and outpatient growth from Mahkota Medical Centre (MMC), Melaka and Regency Specialist Hospital (RSH), Johor. See: Health Management International posts 15% drop in 3Q earnings to $4.4 mil on higher costs According to Phillip, HMI’s average inpatient an....
Read More >>

Jumbo enjoys robust outlook with expansion strategy, but China exposure may pose a problem

SINGAPORE (May 22): CGS-CIMB Research and UOB Kay Hian are maintaining their “add” and “hold” calls on Jumbo Group with target prices of 52 cents and 41 cents, respectively, after the group’s 2Q19 results came in line with both research houses’ expectations. In a report last Wednesday, CGS-CIMB analyst Colin Tan says he expects the first Jumbo Seafood restaurant in South Korea, which is due to begin operations in 3Q19, to add to Jumbo’s growing franchise income stream going forward. He is also positive on the group’s expansion plans through “less risky franchises” in ....
Read More >>